Ownership and insider activity for Zimmer Biomet Holdings, Inc. (ZBH): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific.
Price
| Price | $91.57 |
| Market Cap | $17.7B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-10-01 | Campbell Gary Craig | M-Exempt | 1,218 | |
| 2026-10-01 | Campbell Gary Craig | M-Exempt | 1,218 | |
| 2026-10-01 | Campbell Gary Craig | M-Exempt | 2,368 | |
| 2026-10-01 | Campbell Gary Craig | F-InKind | 480 | $42K |
| 2026-10-01 | Campbell Gary Craig | F-InKind | 932 | $82K |
| 2026-10-01 | Campbell Gary Craig | M-Exempt | 2,368 | |
| 2026-10-01 | Hatcher Brian Matthew | |||
| 2026-10-01 | Hatcher Brian Matthew | 1,407 | $156K | |
| 2026-10-01 | Hatcher Brian Matthew | 857 | $95K | |
| 2026-10-01 | Hatcher Brian Matthew | 6,201 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $634.1M | $524.4M | $542.8M | $617.9M | $802.1M | $378.1M | $375.7M | $415.8M | $525.5M | $591.9M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $1.60B | $1.54B | $1.28B | $1.36B | $1.45B | $1.26B | $1.38B | $1.44B | $1.48B | $1.70B |
| Inventory | $1.97B | $2.08B | $2.26B | $2.38B | $2.45B | $2.15B | $2.15B | $2.39B | $2.24B | $2.29B |
| Total Current Assets | $4.67B | $4.58B | $4.43B | $4.72B | $5.08B | $4.88B | $4.43B | $4.61B | $4.67B | $5.12B |
| Property, Plant & Equipment | $2.04B | $2.04B | $2.02B | $2.08B | $2.05B | $1.84B | $1.87B | $2.06B | $2.05B | $2.21B |
| Goodwill | $10.64B | $10.67B | $9.59B | $9.60B | $9.26B | $8.92B | $8.58B | $8.82B | $8.95B | $9.95B |
| Intangible Assets | $8.79B | $8.35B | $7.68B | $7.26B | $7.06B | $5.53B | $5.06B | $4.86B | $4.60B | $4.72B |
| Total Assets | $26.68B | $26.01B | $24.13B | $24.64B | $24.42B | $23.46B | $21.07B | $21.50B | $21.37B | $23.09B |
| Accounts Payable | $364.5M | $330.2M | $362.6M | $400.9M | $330.0M | $306.5M | $354.1M | $410.6M | $194.6M | $303.0M |
| Short-term Debt | $575.6M | $1.23B | $525.0M | $1.50B | $500.0M | $1.61B | $544.3M | $900.0M | $863.0M | $587.1M |
| Total Current Liabilities | $2.38B | $3.07B | $2.42B | $3.44B | $2.56B | $3.47B | $2.36B | $2.86B | $2.45B | $2.58B |
| Long-term Debt | $10.67B | $8.92B | $8.41B | $6.72B | $7.63B | $5.46B | $5.15B | $4.87B | $5.34B | $6.93B |
| Total Liabilities | $17.01B | $14.28B | $12.85B | $12.25B | $12.22B | $10.79B | $9.04B | $9.01B | $8.89B | $10.39B |
| Retained Earnings | $8.47B | $10.02B | $9.49B | $10.43B | $10.09B | $10.29B | $9.56B | $10.38B | $11.10B | $11.61B |
| Total Equity | $9.67B | $11.74B | $11.27B | $12.39B | $12.19B | $12.66B | $12.02B | $12.48B | $12.47B | $12.70B |
| Total Debt | $11.24B | $10.14B | $8.94B | $8.22B | $8.13B | $7.07B | $5.70B | $5.77B | $6.20B | $7.52B |
| Net Debt | $10.61B | $9.62B | $8.40B | $7.60B | $7.32B | $6.69B | $5.32B | $5.35B | $5.68B | $6.93B |
| Working Capital | $2.29B | $1.51B | $2.01B | $1.28B | $2.53B | $1.42B | $2.07B | $1.75B | $2.22B | $2.54B |
Financial Health
| Debt / Equity | 0.59 |
| Current Ratio | 1.69 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 2.42 |
Profitability
| Return on Equity | 6.36% |
| Return on Invested Capital | 5.51% |
| Return on Assets | 3.54% |
| Gross Margin | 69.87% |
| Operating Margin | 15.73% |
| Net Margin | 9.48% |
Related companies: DGX · DXCM · ILMN · INCY · LH · SNN · STE
Explore sector: Healthcare · Medical - Devices
More sections of ZBH: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks